Followers | 62 |
Posts | 9563 |
Boards Moderated | 0 |
Alias Born | 03/29/2015 |
Wednesday, June 16, 2021 5:58:13 PM
Almost any criticism can be rebutted by "We don't know what they know" and I believe this rebuttal is invalid because it is generally NWBO that prevents us from knowing more than a small fraction of what they know.
It is almost like Enron where people including seasoned analysts had to take on faith that nothing illegal was going on despite the profit increases year over year being suspicious because after all, how could such a big company with so many respected people involved be a scam? Don't they know they would face serious charges and are going to get caught? That must mean everything is being done legally and the lack of transparency is required to protect their competitive advantage. Naturally the few analysts who initially had issues were attacked and sidelined.
We should not have to wait to find out when TLD is released, especially since management gets to control the timetable for TLD (they tacked on the article not the FDA for example).
Now maybe side from a blip on the management's team's resume the parallels are irrelevant. They probably are since NWBO is not pretending to make profits as Enron pretended (we were just discussing NWBO's telling us they will not make money in the near future from sales of products after all).
But I do not believe that management can create an information blackout and then get to use it or for anyone else to get to use as the answer to any concerns.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM